BBHC
RDY icon

Brown Brothers Harriman & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Brown Brothers Harriman & Co’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Hold
1,000
– – ﹤0.01% 1350
2026
Q1 		$13.8K Hold
1,000
– – ﹤0.01% 1300
2025
Q4 		$14K Buy
1,000
+500
+100% +$7.01K ﹤0.01% 1273
2025
Q3 		$6.99K Sell
500
-461
-48% -$6.63K ﹤0.01% 1344
2025
Q2 		$14.4K Buy
+961
New +$13.7K ﹤0.01% 1145
2018
Q4 		– Sell
-1,000
Closed -$7K – 977
2018
Q3 		$7K Buy
+1,000
New +$6.68K ﹤0.01% 724

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Brothers Harriman & Co's RDY Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 1,000 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Brown Brothers Harriman & Co first reported a position in RDY in Q3 2018 and has held it in 6 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Brown Brothers Harriman & Co held 1,000 shares of Dr. Reddy's Laboratories worth $14.5K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1350 holding.
  • Brown Brothers Harriman & Co first reported a position in Dr. Reddy's Laboratories in Q3 2018 and has held it in 6 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.